Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

231.09
-1.9800-0.85%
Post-market: 231.090.00000.00%19:59 EDT
Volume:992.17K
Turnover:229.84M
Market Cap:25.51B
PE:24.54
High:233.33
Open:232.74
Low:230.47
Close:233.07
52wk High:248.84
52wk Low:171.18
Shares:110.37M
Float Shares:110.00M
Volume Ratio:0.93
T/O Rate:0.90%
Dividend:3.32
Dividend Rate:1.44%
EPS(TTM):9.42
EPS(LYR):8.75
ROE:14.60%
ROA:6.40%
PB:3.39
PE(LYR):26.41

Loading ...

Quest Diagnostics Sets BRL 1.5-Per-Unit Distribution for Oct. 27 Payment

Reuters
·
Aug 14

Quest Diagnostics Keeps Quarterly Dividend at $0.86 per Share, Payable Oct. 21, to Shareholders of Record Oct. 6

MT Newswires Live
·
Aug 13

Press Release: Quest Diagnostics Declares Quarterly Cash Dividend

Dow Jones
·
Aug 13

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 07

DaVita Inc. Stock Falls 4.3%, Underperforms Peers

Dow Jones
·
Aug 07

CVS Health Stock And Other Dividend Compounders For Higher Rates

Simply Wall St.
·
Aug 06

Quest Diagnostics (DGX) Lifts 2026 Outlook As Investors Ask If The Stock Is Fully Valued

Simply Wall St.
·
Aug 06

The Science Lab Where Technicians are Drowning in Feces

Dow Jones
·
Aug 05

ROI-Europe Makes Trillion-euro Bet to Revive Its Battered Industry: Bousso

Reuters
·
Jul 31

Argus Research Adjusts Quest Diagnostics Price Target to $260 From $225, Maintains Buy Rating

MT Newswires Live
·
Jul 30

Labcorp Raises Annual Profit Forecast on Strong Testing Demand

Reuters
·
Jul 30

Quest Diagnostics SVP, Chief Commercial Officer Mark E. Delaney Sells 1,600 Shares for $376,288

Reuters
·
Jul 30

Quest Diagnostics price target raised to $260 from $225 at Argus

TIPRANKS
·
Jul 29

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Quest Diagnostics (DGX) and Otsuka Holdings Co (OtherOTSKF)

TIPRANKS
·
Jul 29

Truist Financial Sticks to Their Hold Rating for Quest Diagnostics (DGX)

TIPRANKS
·
Jul 29

Quest Diagnostics is Maintained at Neutral by JP Morgan

Dow Jones
·
Jul 28

Quest Diagnostics Inc : JP Morgan Raises Target Price to $250 from $220

THOMSON REUTERS
·
Jul 28

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 28

Rothschild & Co Redburn Adjusts Quest Diagnostics Price Target to $251 From $233, Maintains Buy Rating

MT Newswires Live
·
Jul 27

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Roche Holding AG (OtherRHHVF) and Quest Diagnostics (DGX)

TIPRANKS
·
Jul 24